Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants. - Wikidata - awgldk - TriplyDB

Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants.

Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants.

http://www.wikidata.org/entity/Q37713019

about

Pharmacokinetic Study of Praziquantel Enantiomers and Its Main Metabolite R-trans-4-OH-PZQ in Plasma, Blood and Dried Blood Spots in Opisthorchis viverrini-Infected Patients Dosing in neonates: special considerations in physiology and trial design.Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct.Adverse consequences of neonatal antibiotic exposure Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data.Blood kinetics of Ebola virus in survivors and nonsurvivors.New antibiotic dosing in infants.Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience.Ethics of drug research in the pediatric intensive care unit.Dosing antibiotics in neonates: review of the pharmacokinetic data.Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.Use of Population Pharmacokinetics and Electronic Health Records to Assess Piperacillin-Tazobactam Safety in Infants.Dose optimization of piperacillin/tazobactam in critically ill children.Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates.Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.Advances in Pediatric Pharmacology, Therapeutics, and Toxicology.A validated LC–MS/MS method for the quantification of piperacillin/tazobactam on dried blood spot

P2860

Q28551880-191EB3A9-8C32-4790-AB0F-A1FF3C9A3203 Q34716879-57F59A87-F713-4B59-B622-9DF5524E4450 Q35135932-31F64820-E7C3-4CA2-93AC-E6578F6710CA Q35926313-697B4FAD-6140-4B93-B19D-3E5A0EEA44FB Q36307045-2A5C7F2E-27A6-4610-A798-27F3102FE9D1 Q36335941-F4BD7B8C-EBE6-4718-8278-F48AAFCCDA0A Q36438111-B9FF05E5-5AD4-4029-B440-1E168D2A35CA Q36439015-47F37E98-217D-494D-A957-FFD1F6FFBBAA Q37203671-6A48C335-7159-469E-91B7-5188AA873275 Q38263726-7ACCFE6B-D769-437D-B098-4D264A61F228 Q38649419-0FBFB055-CAE4-40C4-BF4E-13241B4AE18A Q38696468-37139413-B7D9-4311-9D0B-300314A8B79F Q38819770-73221C7A-2990-4239-8B8F-F38294A6880E Q38836711-9CF5B7F7-7D45-4380-AA11-2B0E0AC817D9 Q38848103-283EE20E-F55D-40C6-A7F0-DD0290DABC60 Q48559800-EFE30F4C-B888-4808-8569-C6774F5BE9B4 Q50468318-7593D2A1-B29B-4B27-8E16-EEAEDDEE740C Q54194778-DDD61BC0-C4D5-4417-9092-1FA5ABB17CA7 Q57728123-763FB56C-2237-463D-96FE-7D4D9F75A6FA

P2860

Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants.

http://www.wikidata.org/entity/Q37713019

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Developmental pharmacokinetics ...... ried blood spots from infants.

@en

Developmental pharmacokinetics ...... ried blood spots from infants.

@nl

type

label

Developmental pharmacokinetics ...... ried blood spots from infants.

@en

Developmental pharmacokinetics ...... ried blood spots from infants.

@nl

prefLabel

Developmental pharmacokinetics ...... ried blood spots from infants.

@en

Developmental pharmacokinetics ...... ried blood spots from infants.

@nl

P1433

Q37713019-A0345A6B-35CB-4878-B6D6-632F97C61E29

P1476

Q37713019-A5E36A9A-103C-432A-82D8-265EA34537B0

P2093

Q37713019-11943BB9-1ED3-42E8-8D82-52A29E30C455

Q37713019-1882DCC5-F1A3-452E-8042-7084667FB77D

Q37713019-264DA829-DFB6-48B1-BF27-0E8583DE1E74

Q37713019-49B91A31-9D21-49B0-9984-949E2419FFD0

Q37713019-6DE25EFD-0E63-4FA3-9266-97649844B933

Q37713019-9086E402-971D-4179-86BF-CC1561D9C635

Q37713019-95CFD2EC-B39C-4B2D-AEB2-9850F69FBE4E

Q37713019-AA304422-B9A1-4A49-BD26-E9D2EB654116

Q37713019-BE742B17-BF02-4477-933D-5956C95A34BE

Q37713019-EDBE21B9-694A-4166-B393-70F851F6D12A

P2860

Q37713019-1A88BE2F-F718-4FFD-9028-3BCFA3B40EA1

Q37713019-1B82DC62-9E05-42EE-B89E-903166DDA7B0

Q37713019-44942244-7762-4FC0-8546-249050142BC3

Q37713019-4C060345-FB7B-4D99-9C3C-F1935D13AA21

Q37713019-53A72E48-6DCF-458B-842A-C72FB2A27988

Q37713019-5A46BA9B-9EDE-472F-B938-C999499056B1

Q37713019-5D569BA2-EB0D-4662-B864-A006791BDB1F

Q37713019-5E8F7E62-74F0-4C85-B1AE-91BD9AD45D6B

Q37713019-6171191E-9C8B-42AE-B9D2-6C906EC3BFE8

Q37713019-6439DA27-347B-41AB-8F54-1A3414A27AEB

P304

Q37713019-C0E7B8E4-CBE4-412D-B8AE-0FFB2CD40017

P31

Q37713019-5749FC90-5755-4B6C-8D8C-0BEC8B78A2CE

P356

Q37713019-949A87D6-38DD-4A56-BE1E-D4D1911A25DA

P407

Q37713019-F32F4D70-F3B8-4612-B1D6-85C554129400

P433

Q37713019-9D1B4B84-87FB-4EEE-9101-F175296175BD

P478

Q37713019-ABF0DCCE-1DBC-441E-9B9F-FCA12B3EBE5B

P577

Q37713019-4B0E6E2F-7D48-4789-A7B8-AE9984EF05D6

P698

Q37713019-DFDA988A-258E-453A-8FF0-53B7FDB07DD6

P932

Q37713019-9BDDD8B6-A2D3-4525-A089-1A9C99006403

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Developmental pharmacokinetics ...... ried blood spots from infants.

@en

P2093

Barry T Bloom

http://www.w3.org/2001/XMLSchema#string

Brenda Poindexter

http://www.w3.org/2001/XMLSchema#string

Chenguang Zhou

http://www.w3.org/2001/XMLSchema#string

Daniel K Benjamin

http://www.w3.org/2001/XMLSchema#string

Edmund V Capparelli

http://www.w3.org/2001/XMLSchema#string

Jamie Gao

http://www.w3.org/2001/XMLSchema#string

Kevin M Watt

http://www.w3.org/2001/XMLSchema#string

Lisa Castro

http://www.w3.org/2001/XMLSchema#string

Michael Cohen-Wolkowiez

http://www.w3.org/2001/XMLSchema#string

P Brian Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections

Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants

Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients.

Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.

Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation

Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.

Development of a liquid chromatography-tandem mass spectrometry assay of six antimicrobials in plasma for pharmacokinetic studies in premature infants.

Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants

Use of the complete blood cell count in early-onset neonatal sepsis

Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infections

P304

2856-2865

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02139-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24614369

http://www.w3.org/2001/XMLSchema#string

P932

3993246

http://www.w3.org/2001/XMLSchema#string